$AGRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGILE THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AGILE THERAPEUTICS INC. Get notifications about new insider transactions in AGILE THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | AGRX | AGILE THERAPEUTICS ... | Carson Sandra | Director | Option Exercise | A | 1.53 | 29,905 | 45,755 | 29,905 | |
Jun 11 2021 | AGRX | AGILE THERAPEUTICS ... | Carson Sandra | Director | Grant | A | 0.00 | 24,510 | 0 | 51,296 | 26.8 K to 51.3 K (+91.50 %) |
Jun 10 2021 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Option Exercise | A | 1.53 | 29,905 | 45,755 | 29,905 | |
Jun 10 2021 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Grant | A | 0.00 | 24,510 | 0 | 55,852 | 31.3 K to 55.9 K (+78.20 %) |
May 12 2021 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Buy | P | 1.35 | 20,000 | 27,000 | 176,306 | 156.3 K to 176.3 K (+12.80 %) |
Apr 06 2021 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 2.87 | 450,000 | 1,291,500 | 450,000 | |
Mar 23 2021 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.00 | 12,500 | 25,030 | 468,710 | 456.2 K to 468.7 K (+2.74 %) |
Mar 23 2021 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Buy | P | 2.05 | 50,000 | 102,500 | 156,306 | 106.3 K to 156.3 K (+47.03 %) |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.82 | 692,641 | 1,953,248 | 692,641 | |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 2.82 | 259,740 | 732,467 | 259,740 | |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Chief Supply Ch ... | Option Exercise | A | 2.82 | 173,160 | 488,311 | 173,160 | |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Chief Supply Ch ... | Grant | A | 0.00 | 35,461 | 0 | 58,357 | 22.9 K to 58.4 K (+154.88 %) |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Option Exercise | A | 2.82 | 303,030 | 854,545 | 303,030 | |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Korner Paul | Sr. VP and CMO | Option Exercise | A | 2.82 | 173,160 | 488,311 | 173,160 | |
Jan 28 2021 | AGRX | AGILE THERAPEUTICS ... | Butch Jason | Principal Accountin ... | Option Exercise | A | 2.82 | 25,000 | 70,500 | 25,000 | |
Nov 23 2020 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Chief Supply Ch ... | Option Exercise | M | 1.76 | 4,149 | 7,302 | 0 | |
Nov 23 2020 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Chief Supply Ch ... | Buy | M | 1.76 | 4,149 | 7,302 | 22,896 | 18.7 K to 22.9 K (+22.13 %) |
Sep 28 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Buy | P | 2.85 | 9,000 | 25,650 | 106,306 | 97.3 K to 106.3 K (+9.25 %) |
Aug 26 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Option Exercise | M | 1.01 | 37,500 | 37,875 | 112,500 | |
Aug 26 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Grant | A | 1.01 | 37,500 | 37,875 | 97,306 | 59.8 K to 97.3 K (+62.70 %) |
Aug 20 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 1.76 | 94,599 | 166,494 | 0 | |
Aug 20 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 1.76 | 94,599 | 166,494 | 456,210 | 361.6 K to 456.2 K (+26.16 %) |
Aug 17 2020 | AGRX | AGILE THERAPEUTICS ... | Korner Paul | Sr. VP & Chief Medi ... | Option Exercise | A | 2.87 | 150,000 | 430,500 | 150,000 | |
Jun 23 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 1.76 | 50,000 | 88,000 | 94,599 | |
Jun 23 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 1.76 | 50,000 | 88,000 | 361,611 | 311.6 K to 361.6 K (+16.05 %) |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Option Exercise | A | 2.80 | 22,606 | 63,297 | 22,606 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Grant | A | 0.00 | 13,393 | 0 | 31,342 | 17.9 K to 31.3 K (+74.62 %) |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Option Exercise | A | 2.80 | 22,606 | 63,297 | 22,606 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Grant | A | 0.00 | 13,393 | 0 | 31,342 | 17.9 K to 31.3 K (+74.62 %) |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Option Exercise | A | 2.80 | 22,606 | 63,297 | 22,606 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Grant | A | 0.00 | 13,393 | 0 | 38,342 | 24.9 K to 38.3 K (+53.68 %) |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Option Exercise | A | 2.80 | 22,606 | 63,297 | 22,606 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Grant | A | 0.00 | 13,393 | 0 | 31,342 | 17.9 K to 31.3 K (+74.62 %) |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Carson Sandra | Director | Option Exercise | A | 2.80 | 45,212 | 126,594 | 45,212 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | Carson Sandra | Director | Grant | A | 0.00 | 26,786 | 0 | 26,786 | 0 to 26.8 K |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | BARBARI SHARON | Director | Option Exercise | A | 2.80 | 45,212 | 126,594 | 45,212 | |
Jun 11 2020 | AGRX | AGILE THERAPEUTICS ... | BARBARI SHARON | Director | Grant | A | 0.00 | 26,786 | 0 | 26,786 | 0 to 26.8 K |
Mar 17 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.75 | 1,000,000 | 1,750,000 | 15,919,925 | 14.9 M to 15.9 M (+6.70 %) |
Mar 16 2020 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Grant | A | 1.56 | 25,500 | 39,780 | 81,283 | 55.8 K to 81.3 K (+45.71 %) |
Mar 06 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Buy | P | 2.35 | 25,000 | 58,750 | 25,000 | 0 to 25 K |
Mar 06 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Buy | P | 2.32 | 50,000 | 116,000 | 59,806 | 9.8 K to 59.8 K (+509.89 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.71 | 16,541 | 11,744 | 0 | |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.71 | 16,541 | 11,744 | 0 | |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.71 | 10,000 | 27,100 | 311,611 | 301.6 K to 311.6 K (+3.32 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 2.71 | 10,000 | 27,100 | 311,611 | 301.6 K to 311.6 K (+3.32 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.71 | 16,541 | 11,744 | 301,611 | 285.1 K to 301.6 K (+5.80 %) |
Feb 27 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.71 | 16,541 | 11,744 | 301,611 | 285.1 K to 301.6 K (+5.80 %) |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 4.67 | 700,000 | 3,269,000 | 700,000 | |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | J | 3.74 | 700,000 | 2,618,000 | 700,000 | |
Feb 25 2020 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.00 | 3,000,000 | 9,000,000 | 14,919,925 | 11.9 M to 14.9 M (+25.17 %) |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 2.83 | 316,667 | 896,168 | 316,667 | |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Grant | A | 0.00 | 10,071 | 0 | 55,783 | 45.7 K to 55.8 K (+22.03 %) |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Option Exercise | A | 2.83 | 308,333 | 872,582 | 308,333 | |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Grant | A | 0.00 | 9,806 | 0 | 9,806 | 0 to 9.8 K |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.83 | 833,333 | 2,358,332 | 833,333 | |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Grant | A | 0.00 | 26,502 | 0 | 285,070 | 258.6 K to 285.1 K (+10.25 %) |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | Sr. VP Manufacturin ... | Option Exercise | A | 2.83 | 197,222 | 558,138 | 197,222 | |
Jan 24 2020 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | Sr. VP Manufacturin ... | Grant | A | 0.00 | 6,272 | 0 | 12,547 | 6.3 K to 12.5 K (+99.95 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.74 | 333,800 | 580,812 | 11,919,925 | 11.6 M to 11.9 M (+2.88 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.60 | 2,000,000 | 3,200,000 | 11,586,125 | 9.6 M to 11.6 M (+20.86 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.72 | 3,000,000 | 5,160,000 | 9,586,125 | 6.6 M to 9.6 M (+45.55 %) |
Nov 18 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 1.69 | 435,015 | 735,175 | 6,586,125 | 6.2 M to 6.6 M (+7.07 %) |
Oct 31 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 0.44 | 760,291 | 334,528 | 6,151,110 | 6.9 M to 6.2 M (-11.00 %) |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 0.51 | 3,815,349 | 1,945,828 | 6,911,401 | 10.7 M to 6.9 M (-35.57 %) |
Oct 30 2019 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 0.95 | 2,300,000 | 2,185,000 | 10,726,750 | 8.4 M to 10.7 M (+27.29 %) |
Aug 06 2019 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Option Exercise | A | 1.01 | 150,000 | 151,500 | 150,000 | |
Aug 06 2019 | AGRX | AGILE THERAPEUTICS ... | Reilly Dennis | Chief Financial Off ... | Option Exercise | A | 1.01 | 150,000 | 151,500 | 150,000 | |
Jul 08 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 1.48 | 150,000 | 222,000 | 150,000 | |
Jul 08 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 1.48 | 75,000 | 111,000 | 75,000 | |
Jun 11 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 1.27 | 20,000 | 25,400 | 258,568 | 238.6 K to 258.6 K (+8.38 %) |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | MCKEE WILLIAM | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | Lele Abhijeet J | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Jun 07 2019 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Option Exercise | A | 1.03 | 75,000 | 77,250 | 75,000 | |
Apr 01 2019 | AGRX | AGILE THERAPEUTICS ... | Lele Abhijeet J | Director | Buy | P | 1.54 | 20,000 | 30,800 | 37,949 | 17.9 K to 37.9 K (+111.43 %) |
Mar 26 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | P | 1.54 | 25,000 | 38,500 | 238,568 | 213.6 K to 238.6 K (+11.71 %) |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 2.50 | 38,500 | 96,250 | 38,500 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 0.84 | 172,600 | 144,984 | 172,600 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 2.50 | 15,000 | 37,500 | 15,000 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 0.84 | 85,000 | 71,400 | 85,000 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | A | 2.50 | 38,500 | 96,250 | 38,500 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | A | 0.84 | 172,600 | 144,984 | 172,600 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 2.50 | 38,500 | 96,250 | 38,500 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.84 | 172,600 | 144,984 | 172,600 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 2.50 | 154,400 | 386,000 | 154,400 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.84 | 540,900 | 454,356 | 540,900 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | M | 0.00 | 8,625 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Payment of Exercise | F | 0.89 | 2,350 | 2,083 | 6,275 | 8.6 K to 6.3 K (-27.25 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Buy | M | 0.00 | 8,625 | 0 | 8,625 | 0 to 8.6 K |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 18,565 | 0 | 17,500 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 17,500 | 0 | 47,800 | 30.3 K to 47.8 K (+57.76 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 18,565 | 0 | 30,300 | 11.7 K to 30.3 K (+158.20 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 16,070 | 0 | 17,500 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 17,500 | 0 | 48,256 | 30.8 K to 48.3 K (+56.90 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 16,070 | 0 | 30,756 | 14.7 K to 30.8 K (+109.42 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | M | 0.00 | 16,480 | 0 | 17,500 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Buy | M | 0.00 | 17,500 | 0 | 45,712 | 28.2 K to 45.7 K (+62.03 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Buy | M | 0.00 | 16,480 | 0 | 28,212 | 11.7 K to 28.2 K (+140.47 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | M | 0.00 | 35,314 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Buy | M | 0.00 | 35,314 | 0 | 213,568 | 178.3 K to 213.6 K (+19.81 %) |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | Sell | S | 0.30 | 298,628 | 89,439 | 3,231,372 | 3.5 M to 3.2 M (-8.46 %) | |
Jul 26 2018 | AGRX | AGILE THERAPEUTICS ... | PERCEPTIVE ADVISORS LLC | Sell | S | 0.30 | 298,628 | 89,439 | 3,231,372 | 3.5 M to 3.2 M (-8.46 %) | |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 0.58 | 75,000 | 43,500 | 75,000 | |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | ALTOMARI ALFRED | Chief Executive Off ... | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | MCKEE WILLIAM | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | MCKEE WILLIAM | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | MCKEE WILLIAM | Director | Buy | M | 0.00 | 17,949 | 0 | 17,949 | 0 to 17.9 K |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Fischer Seth H. Z. | Director | Buy | M | 0.00 | 17,949 | 0 | 17,949 | 0 to 17.9 K |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Hubbard John W | Director | Buy | M | 0.00 | 17,949 | 0 | 17,949 | 0 to 17.9 K |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Tursi James Patrick | Director | Buy | M | 0.00 | 17,949 | 0 | 17,949 | 0 to 17.9 K |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Shetty Ajit | Director | Buy | M | 0.00 | 17,949 | 0 | 24,949 | 7 K to 24.9 K (+256.41 %) |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Lele Abhijeet J | Director | Option Exercise | M | 0.00 | 17,949 | 0 | 0 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Lele Abhijeet J | Director | Option Exercise | A | 0.60 | 50,000 | 30,000 | 50,000 | |
Jun 08 2018 | AGRX | AGILE THERAPEUTICS ... | Lele Abhijeet J | Director | Buy | M | 0.00 | 17,949 | 0 | 17,949 | 0 to 17.9 K |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 33,570 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.00 | 16,070 | 0 | 51,070 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 3.46 | 107,000 | 370,220 | 107,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Payment of Exercise | F | 3.32 | 6,753 | 22,420 | 14,686 | 21.4 K to 14.7 K (-31.50 %) |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 17,500 | 0 | 21,439 | 3.9 K to 21.4 K (+444.28 %) |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | M | 0.00 | 17,500 | 0 | 33,980 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 0.00 | 16,480 | 0 | 51,480 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Option Exercise | A | 3.46 | 107,000 | 370,220 | 107,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Payment of Exercise | F | 3.32 | 5,768 | 19,150 | 11,732 | 17.5 K to 11.7 K (-32.96 %) |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Gilmore Geoffrey | General Counsel | Buy | M | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 0.00 | 8,625 | 0 | 8,625 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Conway Robert G | SVP Ent Planning & ... | Option Exercise | A | 3.46 | 85,000 | 294,100 | 85,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | M | 0.00 | 17,500 | 0 | 36,065 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | A | 0.00 | 18,565 | 0 | 53,565 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Option Exercise | A | 3.46 | 107,000 | 370,220 | 107,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Payment of Exercise | F | 3.32 | 5,765 | 19,140 | 11,735 | 17.5 K to 11.7 K (-32.94 %) |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Garner Elizabeth | Sr. VP & Chief Medi ... | Buy | M | 0.00 | 17,500 | 0 | 17,500 | 0 to 17.5 K |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Selman Renee | Chief Commercial Of ... | Option Exercise | M | 0.00 | 17,500 | 0 | 30,700 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Selman Renee | Chief Commercial Of ... | Option Exercise | A | 0.00 | 13,200 | 0 | 48,200 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Selman Renee | Chief Commercial Of ... | Option Exercise | A | 3.46 | 107,000 | 370,220 | 107,000 |